Minireviews
World J Hepatol
9(25):1043-1053.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1043
Abstract (647)
|
Core Tip (647)
|
Full Article (HTML) (2569)
|
Tables (1-3) (92)
|
Full Article (PDF)-1379K (469)
|
Full Article (Word)-197K (112)
|
Audio-718K (14)
|
Peer-Review Report-94K (117)
|
Answering Reviewers-128K (126)
|
Received: 05/27/2017
|
Revised: 07/13/2017
|
Accepted: 08/04/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (8346)
|
Similar Articles (354)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
9(25):1054-1063.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1054
Abstract (729)
|
Core Tip (554)
|
Full Article (HTML) (2964)
|
Full Article (PDF)-1369K (593)
|
Full Article (Word)-183K (191)
|
Audio-468K (12)
|
Peer-Review Report-78K (177)
|
Answering Reviewers-64K (122)
|
Received: 01/26/2017
|
Revised: 07/18/2017
|
Accepted: 08/16/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (9413)
|
Similar Articles (173)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions

World J Hepatol
9(25):1064-1072.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1064
Abstract (775)
|
Core Tip (580)
|
Full Article (HTML) (2438)
|
Figures (1-2) (99)
|
Tables (1-2) (104)
|
Full Article (PDF)-1444K (283)
|
Full Article (Word)-2913K (131)
|
Audio-2584K (13)
|
Peer-Review Report-98K (109)
|
Answering Reviewers-81K (90)
|
Received: 03/16/2017
|
Revised: 05/17/2017
|
Accepted: 07/17/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (10089)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients

World J Hepatol
9(25):1073-1080.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1073
Abstract (618)
|
Core Tip (548)
|
Full Article (HTML) (2427)
|
Figures (1-3) (119)
|
Tables (1-2) (103)
|
Full Article (PDF)-1721K (322)
|
Full Article (Word)-9799K (155)
|
Audio-547K (20)
|
Peer-Review Report-82K (79)
|
Answering Reviewers-134K (87)
|
Received: 01/04/2017
|
Revised: 04/29/2017
|
Accepted: 05/24/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (10912)
|
Similar Articles (102)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open